Hubei issued new policies to promote the high-quality development of biomedical industry from five aspects
-
Last Update: 2019-12-12
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
[policies and regulations of pharmaceutical network] in recent years, Hubei has made great efforts to expand the total scale of biomedicine and high-end medical device industry, and promote the transformation and upgrading of biomedical industry It is understood that on December 4, Hubei Provincial Food and Drug Administration issued "several measures to promote the high-quality development of biomedical industry in our province", a total of 20 policies and measures in 5 aspects, to further promote the quality and efficiency of administrative services for drugs, medical devices and cosmetics, and promote the high-quality development of biomedical industry in the province The measures include improving the review and approval mechanism, simplifying the review and approval process, encouraging product R & D innovation, supporting enterprises to grow stronger and maintain good market order, etc For example, in the aspect of simplifying the process, the measures point out that in the process of canceling the preliminary examination at the municipal level in the examination and approval of drugs (except special drugs), medical devices registration and production and operation, the enterprise directly applies to the Provincial Bureau; establishing a rapid examination and approval procedure, and granting immediate approval for those included in the immediate matters; and taking notification and acceptance for the administrative examination and approval items that do not need on-site inspection, sample testing and technical review The enterprise shall be responsible for the authenticity and compliance of the submitted materials In terms of encouraging product R & D and innovation, Hubei food and Drug Administration will speed up the inspection and testing services, start the urgent inspection and testing procedures for innovative drugs and first generic drugs, explore and encourage the third-party inspection and testing institutions to carry out the inspection of drugs, cosmetics and medical devices, promote the consistency evaluation of the quality and efficacy of generic drugs, regularly answer the actual problems faced by enterprises, and guide the project to Next, accelerate the enterprise to pass the consistency evaluation It is understood that at present, Hubei Province's biomedical industry focuses on six major areas of industrial development, including biological medicine, chemical medicine, traditional Chinese medicine, high-end medical devices and biomedical materials, pharmaceutical accessories, packaging materials and pharmaceutical equipment, and health care products Through the implementation of "enhancing industrial innovation ability" and "implementation" The eight key tasks of "giant" cultivation project "," implementation of intelligent manufacturing project "," implementation of green manufacturing project "," implementation of quality management improvement project "," promotion of industrial intensive cluster development "," improvement of open development level "and" development of new fields and new formats "are to promote innovation and upgrading of pharmaceutical industry and comprehensively improve development quality and efficiency We will make great efforts to make the biomedical industry bigger and stronger Through continuous innovation and development, Hubei pharmaceutical industry has also made some achievements Data shows that in 2018, the total economic volume of Hubei Province exceeded 3.9 trillion yuan, an increase of 7.8% over the previous year The added value of industries above designated size increased by 7.1% over the previous year, of which the added value of Pharmaceutical Enterprises above designated size increased by 9.2% year-on-year, 2.1 percentage points higher than the industry of the whole province; the main business income was 125.23 billion yuan, 16.8% higher than the industry of the whole Province, 8.6% higher; the total profit was 11.64 billion yuan, 5.7% higher than the industry of the whole province According to the industry, in recent years, Hubei Province's biomedical industry has made great progress, the chain has been gradually improved, and the layout has been continuously optimized, laying a good foundation for subsequent development For the next step, where will Hubei's biological industry go? Relevant principals have said that they will rely on Wuhan Optics Valley National biological industry base, focus on breaking through a batch of biotechnology with independent intellectual property rights, expand and strengthen a batch of leading enterprises and key products, and enhance the influence of biological industry in Hubei Province Strive to achieve more than 300 billion yuan of main business revenue by 2022 Hubei's "20 new policies" will further promote the upgrading and development of the pharmaceutical industry by improving the review and approval mechanism, simplifying the review and approval process, encouraging product R & D innovation, supporting enterprises to become bigger and stronger, and maintaining a good market order.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.